You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
復星醫藥(600196.SH):擬對蘇州天使基金進行同比例減資

格隆匯7月15日丨復星醫藥(600196.SH)公佈,本集團於2022年1月參與發起設立蘇州天使基金,截至本公告日期,該基金已獲認繳人民幣17,600萬元(已獲實繳人民幣9,425萬元);其中,本集團(通過控股子公司寧波復瀛)認繳人民幣11,000萬元(已實繳人民幣6,125萬元)、星盛復盈認繳人民幣300萬元(已實繳人民幣150萬元)、蘇州天使母基金認繳人民幣6,300萬元(已實繳人民幣3,150萬元),分別持有該基金62.50%、1.70%、35.80%的份額。鑑於該基金投資期即將屆滿並考慮屆滿前投資計劃之資金需求,經各方協商,全體合夥人同意對蘇州天使基金進行同比例減資,減資總額爲人民幣7,600萬元。本次減資完成後,蘇州天使基金財產份額將由人民幣17,600萬元減少至10,000萬元,其中星盛復盈、寧波復瀛、蘇州天使母基金認繳出資額分別減少人民幣129.5455萬元、4,750.0000萬元、2,720.4545萬元。本次減資前後,全體合夥人持有的蘇州天使基金財產份額比例不變。由於本次減資所涉及的蘇州天使基金份額已獲認繳但尚未獲實繳,因此,蘇州天使基金無需就本次減資向各減資方支付對價。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account